BBSRC Portfolio Analyser
Award details
Avipox Viromics
Reference
BBS/E/I/00001019
Principal Investigator / Supervisor
Professor Michael Skinner
Co-Investigators /
Co-Supervisors
Institution
The Pirbright Institute
Department
The Pirbright Institute Department
Funding type
Research
Value (£)
754,046
Status
Completed
Type
Institute Project
Start date
01/04/2003
End date
31/10/2005
Duration
31 months
Abstract
Although we intend to continue targeted study of specific candidate immunomodulators (IL-18bp and, should appropriate opportunities arise, the chemokine-like proteins), the major aim is to develop broad scale viromic approaches using genetics and biochemistry or cell biology. A primary target of the viromics is to develop genetic approaches to identify factors involved in resistance to type I interferon. In one approach, we will screen a bank of pan-genome knockouts for loss of trans-acting resistance to exogenous type I interferon. In a complementary approach, we will screen an expression library for complementation of a defect in resistance to type I interferon. Establishing the mutant bank and expression library will be a major part of the programme but will provide resources available for identification of genes involved in functions other than resistance to type I interferon. Work will continue on the yeast-2-hybrid analysis of interactions between selected FPV proteins and host proteins as well as between a random library of all FPV proteins. In particular, work will address the validity and role of interactions identified.
Summary
unavailable
Committee
Closed Committee - Animal Sciences (AS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search